What is LIPO GANTRISIN used for?

LIPO GANTRISIN is an FDA-approved medication. See full prescribing information for approved uses.

Is LIPO GANTRISIN FDA approved?

Yes, LIPO GANTRISIN is FDA approved (first approved 1953-12-04) and manufactured by Roche.

Who makes LIPO GANTRISIN?

LIPO GANTRISIN is manufactured by Roche.

Data updated: Mar 10, 2026

LIPO GANTRISIN

SULFISOXAZOLE ACETYL

Approved 1953-12-04

Jump to: Indications Approvals Trials Competitors Safety Patents

Indication

Phase 3 Trials

Years on Market

Details

Status: Discontinued
First Approved: 1953-12-04
Routes: ORAL
Dosage Forms: EMULSION

Companies

Roche

Active Ingredient: SULFISOXAZOLE ACETYL

LIPO GANTRISIN Approval History

Loading approval history...

What LIPO GANTRISIN Treats

1 FDA approvals

Originally approved for its first indication in 1953 .

Other (1)

🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

Understanding FDA Approval Types

Count	Type	What it means
-	ORIG	Original approval - drug first enters market
-	SUPPL - Efficacy	New indication (new disease/condition approved)
-	SUPPL - Labeling	Label text changes (warnings, dosing updates)
-	SUPPL - Manufacturing	Production changes (new facility)
-	SUPPL - Chemistry	Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

LIPO GANTRISIN FDA Label Details

Pro

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

FDA Approval: NDA009182 → Patents: FDA Orange Book → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.